Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$739.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Sep 11 | NBIX | Neurocrine Biosciences INC | AGRANT◷ | 3,587 | — | — | +45.4% | Open the original filing on SEC.gov |
| May 26 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 3,888 | $156.64 | $609K | -33.3% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 5,479 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 31,234 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,811 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,541 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 5,378 | $124.12 | $667.5K | -31.7% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT | 9,968 | — | — | +142.6% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 978 | $124.12 | $121.4K | -12.3% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 1,811 | — | — | +29.4% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 832 | $124.12 | $103.3K | -11.9% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 1,541 | — | — | +28.3% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,600 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | FTAX | 864 | $123.10 | $106.4K | -13.7% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER | 1,600 | — | — | +34.0% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,096 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | FTAX | 1,189 | $136.06 | $161.8K | -20.2% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER | 2,096 | — | — | +55.1% | Open the original filing on SEC.gov |